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Abstract
Background: Kyphoplasty represents an established minimal-invasive method for correction and
augmentation of osteoporotic vertebral fractures. Reliable data on perioperative and postoperative
complications are lacking in the literature. The present study was designed to evaluate the
incidence and patterns of perioperative complications in order to determine the safety of this
procedure for patients undergoing kyphoplasty.
Patients and Methods: We prospectively enrolled 102 consecutive patients (82 women and 20
men; mean age 69) with 135 operatively treated fractured vertebrae who underwent a kyphoplasty
between January 2004 to June 2006. Clinical and radiological follow-up was performed for up 6
months after surgery.
Results: Preoperative pain levels, as determined by the visual analogous scale (VAS) were 7.5 +/-
1.3. Postoperative pain levels were significantly reduced at day 1 after surgery (VAS 2.3 +/- 2.2) and
at 6-month follow-up (VAS 1.4 +/- 0.9). Fresh vertebral fractures at adjacent levels were detected
radiographically in 8 patients within 6 months. Two patients had a loss of reduction with
subsequent sintering of the operated vertebrae and secondary spinal stenosis. Accidental cement
extravasation was detected in 7 patients in the intraoperative radiographs. One patient developed
a postoperative infected spondylitis at the operated level, which was treated by anterior
corporectomy and 360 degrees fusion. Another patient developed a superficial wound infection
which required surgical revision. Postoperative bleeding resulting in a subcutaneous haematoma
evacuation was seen in one patient.
Conclusion:  The data from the present study imply that percutaneous kyphoplasty can be
associated with severe intra- and postoperative complications. This minimal-invasive surgical
procedure should therefore be performed exclusively by spine surgeons who have the capability of
managing perioperative complications.
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Background
Osteoporotic vertebral compression fractures (VCF) are
an epidemic burden disabling temporarily or perma-
nently millions of elderly people worldwide. The annual
incidence of VCF is 1.21% in women and 0.68% in men,
increasing markedly with age [1]. With the continued
aging of our population, VCF represent an important
cause of disability and a significant source of healthcare
resource utilization [2]. Non-surgical management with
pain control and physical therapy-assisted mobilization is
an effective treatment option. However, many patients
remain immobilized due to chronic back pain [3]. The
obvious functional and physical consequences of VCF
lead to anxiety, depression, and have devastating impact
on interpersonal relationships and social roles [4]. Strik-
ingly, VCF have been shown to contribute significantly to
shorter life-expectancy both in women (p < 0.01) and
men (p < 0.0001) within one year after onset of symp-
toms [5].
Since restoration of quality of life has grown into a major
issue in VCF treatment, operative treatment for pain
reduction and correction of deformity has been much
sought-after. Galibert et al [6] presented the first cases of
successful vertebral augmentation by intravertebral injec-
tion of polymethyl methacrylate (PMMA) in patients with
vertebral haemagiomas. Later, vertebroplasty was success-
fully introduced for the management of osteoporotic
compression fractures [7]. The primary goal of vertebro-
plasty is pain relief by stabilization of the continuously
sintering VCF [8]. A significant drawback of vertebroplasty
is the fact that prevalent kyphosis cannot be corrected
through this procedure. The biomechanical principle of
increasing anterior column load with progressing kypho-
sis leading to subsequent VCF established the basic ration-
ale for kyphoplasty. With this technique, reduction of VCF
is achieved by a transpedicular intracorporal balloon
expansion and retention by PMMA cement augmentation
[9]. Up to the present, the concept of kyphoplasty has
been successfully applied in thousands of patients with
VCF, by decreasing fracture-related pain, improving bio-
mechanics of the spine, as well as pulmonary function
and quality of life [10,11].
Although kyphoplasty is performed in a minimally-inva-
sive, percutaneous technique, the cement augmentation
of vertebral fractures is associated with intra- and postop-
erative complications [12]. The most commonly
described complication is an extravertebral leakage of
PMMA cement through the venous system and through
vertebral fracture cracks [13]. This can lead to spinal sten-
osis or to pulmonary cement embolism [14]. Even though
kyphoplasty has significantly lower rates of cement
extravasation than vertebroplasty [15], cement leakage
may occur more frequently than appreciated and is asso-
ciated with a significant morbidity [12]. In addition, sys-
temic allergic or toxic reactions to PMMA monomers have
been described [16]. Furthermore, the stabilization of a
specific fracture level by kyphoplasty may lead to second-
ary fractures of adjacent vertebrae due to the changed bio-
mechanics of the spine [17]. The presented study was
designed to assess the overall incidence and patterns of
complications related to the kyphoplasty procedure in
patients with osteoporotic vertebral fractures.
Patients and methods
This prospective study was performed between 1/2004
and 6/2006. Written informed consent was obtained from
all participating individuals. A total number of 102
patients (82 women and 20 men; age: 69 ± 8 years) pre-
sented with 130 fractured vertebrae type A1 and 5 frac-
tured vertebrae type A3 according to the AO classification
by Magerl et al [18] (72 thoracic and 63 lumbar levels).
The activity of osteoporotic VCF was confirmed in all cases
by evaluation of the bony oedema in fat suppressed
sequences (i.e. TIRM or STIR) of the magnetic resonance
imaging (MRI). Furthermore anterior-posterior (a-p) and
lateral radiographs were performed to evaluate the scoli-
otic and kyphotic deformity. Indication for kyphoplasty
was kyphotic deformity >15 degrees, subsequent sintering
(progressive loss of vertebral height), and pain resistant to
analgesics and physical therapy for twelve weeks, as
assessed by a visual analogue scale (VAS) score of more
than 5 points.
As operative procedure we chose in 130 cases a percu-
taneus balloon kyphoplasty (Kyphon Inc, Sunnyvale, CA)
with PMMA cement (Kyphx-HVR; Kyphon Inc.) after
closed reduction through traction and lordosation under
general anaesthesia. In the 5 cases with A3.1 fractures an
additional stabilization with an internal fixator was per-
formed (Universal Spine System; Synthes, Bettlach, Swit-
zerland). During the procedure no biopsies were
performed for pathologic review to rule out tumour as a
cause of the pathologic bon quality. Peri- and postopera-
tively all patients received thrombosis prophylaxis with
low-molecular weight heparins. Perioperatively all
patients received an intravenous single-shot 1.5 g cefurox-
ime.
Follow-up was done 6 weeks, 12 weeks, and 6 months
postoperatively. At follow-up plain radiographs were per-
formed, and cement leakages, subsequent fractures, and
further sintering (vertebral height and kyphosis) were
determined.
Results
Preoperative pain levels, as determined by VAS were 7.5 +/
- 1.3. Postoperative pain levels were significantly reducedPatient Safety in Surgery 2008, 2:2 http://www.pssjournal.com/content/2/1/2
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at day 1 after surgery (VAS 2.3 +/- 2.2) and at 6-month fol-
low-up (VAS 1.4 +/- 0.9).
This study focused on complications of kyphoplasty,
which could be distinguished between late complications
(subsequent VCF, secondary stenosis through sintering)
and early/perioperatively (cement leakage, infection, hae-
matoma). Complications occurred in 18 patients (17.6%)
Fresh vertebral fractures at adjacent levels were detected
radiographically in 8 patients (7.8%) within 6 months
(Fig. 1). Two patients (2.0%) had a loss of reduction with
subsequent sintering of the operated vertebrae and sec-
ondary spinal stenosis (Fig. 2). Accidental cement extrava-
sation was detected in 7 patients (6.9%) in the
intraoperative radiographs (Fig. 3). One of these leakages
(1.0%) was into the spinal canal without any relevant spi-
nal stenosis or neurological compromise. No sign of
cement embolisms or allergic reactions to PMMA mono-
mers was seen. One patient (1.0%) developed two weeks
after kyphoplasty a postoperative infected spondylitis at
the operated level with epidural abscess and incomplete
paraplegia, which was treated emergently by posterior
decompression, abscess evacuation, and instrumentation
as well as anterior debridement and corporectomy in a
360 degrees fusion (Fig. 4). Another patient (1.0%) devel-
oped a superficial wound infection after 10 days which
required surgical revision. Postoperative bleeding result-
ing in a subcutaneous haematoma evacuation was seen in
one patient (1.0%).
Discussion
Fourteen years after the first vertebroplasty was performed
in 1984, the procedure met its worst competitor promis-
ing less complications and reconstructive ability: kypho-
plasty. Until now, several non-randomized prospective
controlled trials have been published comparing kypho-
plasty to non-surgical treatment and vertebroplasty (Table
1) and four ongoing randomized controlled trials are reg-
istered (Table 2) [19]. Major issues are pain improvement
and quality of life, correction of deformity and postoper-
ative complications. The first results of the multicentrical
randomized controlled Fracture Reduction Evaluation
(FREE) study present a significant improvement of the
quality of life (SF-36, p < 0. 01) after 3 months in the
kyphoplasty group (n = 149) controlled against non-sur-
gical treatment (n = 151) [11]. Only one device-related
serious adverse effect (a soft tissue haematoma) has been
reported in the FREE study, but first the 1-year results,
which will be published soon, will give evidence concern-
ing the safety of kyphoplasty.
Correction of deformity
Osteoporotic VCF lead to significantly reduced life expect-
ancy in both men and women [5]. In postmenopausal
women the risk of subsequent VCF is much greater than
for other fractures (relative risk = 4.4) [20,21]. This risk
increases with the severity of the deformity [22]. Therefore
surgical correction of deformity has the ability to reduce
morbidity and mortality in these patients. Conventional
open interventions require anterior open-wedge or poste-
rior closing-wedge techniques with long distance poste-
rior fusions because of poor bone quality. Due to the
surgical access and co-morbidities these operations go
along with severe complications, but they were found to
have excellent 2-year results in ODI and VAS improve-
ment [23]. Much less invasive is the kyphoplasty proce-
A 56-year old lady presented with painful compression fractures at L2, L3, and L4 due to corticoid-induced secondary oste- oporosis (a, b) Figure 1
A 56-year old lady presented with painful compression fractures at L2, L3, and L4 due to corticoid-induced secondary oste-
oporosis (a, b). As pain did not improve during non-surgical therapy for 6 weeks, kyphoplasty at L2–L4 was performed (c). 
Two weeks postoperatively the patient reported again severe back pain. The radiographs revealed an adjacent compression 
fracture at L1 (d). Therefore a kyphoplasty at L1 was performed (e). One month later the patient presented again with severe 
thoracolumbar back pain, because of an adjacent fracture at T12 (f). After kyphoplasty of T12 and prophylactic kyphoplasty of 
T11 the patient remained without further fractures (g).Patient Safety in Surgery 2008, 2:2 http://www.pssjournal.com/content/2/1/2
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dure, which also has the capability of reconstructing VCF
height. Voggenreiter et al [9] found a reduction of 3.1
degrees Cobb angle in standing radiographs after kypho-
plasty (n = 30). Pradhan et al [24] found a local correction
of the fractured vertebra of 7.2 degrees, but only 2.4
degrees of the Cobb angle, when measured 1 level above
and below (n = 65). Interestingly they found a greater
improvement of kyphosis with multilevel kyphoplasty of
7.7 degrees Cobb angle.
Complications after Kyphoplasty
The comprehensive meta-analysis of Taylor et al [19] sum-
marized all published kyphoplasty complications.
Cement leakages occurred in 8.1% of all cases, but only
0.09% were symptomatic. New vertebral fractures
occurred in 11.1%, and 9.4% were adjacent vertebrae.
Pulmonary embolism occurred in 0.17% of all cases. Spi-
nal stenosis with spinal cord compression occurred in
0.16% of all cases. Radiculopathy was found in 0.17% of
all cases. The overall mortality was 4.4%, perioperative
mortality was 0.13%.
Adjacent vertebral fractures
Adjacent fractures are the most common adverse event
found after kyphoplasty. The occurrence of adjacent frac-
tures is known from vertebroplasty, where 12.4% had
subsequent VCF after two years (n = 177) [25]. Kypho-
plasty was thought to have lesser adjacent fractures due to
correction of kyphotic deformity [22], but kyphosis is not
the only reason for adjacent fractures. Lin et al [26] corre-
lated the incidence of adjacent fractures to cement leakage
into the disc in vertebroplasty (n = 38, p < 0.005).
Komemushi et al [27] found cement leakage into the disc
to be a significant predictor of adjacent VCF (n = 83, p <
0.001). These findings will apply to cement leakage in
kyphoplasty, too.
In our study population after 6 months adjacent fractures
were found in 7.8% of all cases (n = 102). Fifty percent of
these patients had secondary osteoporosis due to corti-
coid medication. Fribourg et al [17] found subsequent
A 77-year old man complained about severe thoracolumbar  back pain Figure 3
A 77-year old man complained about severe thoracolumbar 
back pain. Plain radiographs revealed multiple osteoporotic 
vertebral compression fractures (a, b), of which fractures at 
Th9, Th11, and L1 were relatively fresh in the stir-sequence 
of the MRI (c). Because of severe pain resistant to non-surgi-
cal therapy for 2 months we decided to perform kyphoplasty 
at Th9, Th11, and L1. During the procedure the flattened 
vertebra L1 was impossible to reduce (f), while filling the 
vertebra with PMMA cement a leakage occurred into the 
lower disc (g-i). Nevertheless the patient had dramatically 
reduced back pain, presented no sign of neurological damage 
and was released two days after the procedure (d, e).
A 68-year old lady fell on glazed frost and presented with  acute back pain without neurological symptoms Figure 2
A 68-year old lady fell on glazed frost and presented with 
acute back pain without neurological symptoms. The plain 
radiographs revealed osteoporotic fractures at L1 and L2 
type A1.2 according to Magerl et al [18] without spinal sten-
osis in both CT and MRI (a). After kyphoplasty L1 and L2 
and onset of a medical anti-osteoporotic therapy the patient 
was pain-free for one month (b). The kyphotic deformity of 
L1 could be improved from 12 degrees to 6 degrees. Then 
she presented with immobilizing radicular pain radiating into 
the lumbar region. Signs of caudal or conus compression 
were not present. Plain radiographs revealed a sintering of 
the already kyphoplastized vertebra L1 with 14 degrees 
kyphosis (c). CT-scans revealed a significant central and 
foraminal stenosis (d, e) without myelon compression in the 
MRI (f, g). After a microscopically-assisted decompression at 
T12/L1 the patient was pain-free and further sintering did not 
occur thereafter.Patient Safety in Surgery 2008, 2:2 http://www.pssjournal.com/content/2/1/2
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fractures after kyphoplasty in 26% of all cases (n = 38),
21% occurred during the first two months. Harrop et al
[28] found subsequent fractures in 22.6% of all patients
after a mean follow-up of 11 months (n = 115). Sixty-five
percent of these had secondary steroid-induced oste-
oporosis. Another investigation by Lavelle & Cheney [29]
found 17% recurrent fractures within one year after
kyphoplasty, 11.7% occurred during the first 90 days (n =
94). They did not find any impact of secondary oste-
oporosis on subsequent fractures. A prospective investiga-
tion by Moon et al [30] found an incidence of subsequent
VCF in 15.5% patients after one year (n = 111). Interest-
ingly they could correlate the appearance of adjacent VCF
to the amount of PMMA cement applied during the pro-
cedure (p < 0.05).
The available data reveals that subsequent VCF of adjacent
vertebrae occur in 7.8% to 26% of all patients treated with
kyphoplasty. Kyphosis, secondary osteoporosis, and
cement leakage into the intervertebral disc facilitate the
occurrence of subsequent VCF. Identifying risk factors for
subsequent VCF, several authors discussed the indication
for prophylactic cement augmentation of adjacent verte-
brae [[31-33]]. Especially in cases of "sandwich-kypho-
plasty" with an osteoporotic non-fractured vertebra
between two kyphoplasties some recommend a prophy-
lactic kyphoplasty [32]. Until now there is no clinical evi-
dence for the effectiveness of prophylactic vertebro- or
kyphoplasty [32], but the biomechanical investigation of
Sun and Liebschner [31] using finite-elements found a sig-
nificant reinforcement of high-risk vertebral bodies with
prophylactic vertebroplasty. Despite some promising
experimental data, in the light of the present evidence it
rather seems that the prophylactic use of PMMA reduces
the safety of the procedure [31].
Fearing secondary spinal stenosis due to further sintering
of burst fractures after kyphoplasty several surgeons per-
form posterior instrumentation of the adjacent vertebrae
to protect the posterior wall [34]. This can be done using
percutaneous posterior instrumentation or with a conven-
tional open technique. Verlaan et al [35] investigated the
use of kyphoplasty after posterior instrumentation in
burst fractures in 20 patients (mean age 41.8 years). No
bone fragment displacement was found. Unsymptomatic
cement leakage occurred in 5 cases. Vertebral anterior
height could be restored to 91% of the estimated intact
height. Nöldge et al [34] performed kyphoplasty with pos-
terior instrumentation in 9 patients with burst fractures.
They found a reduction of mean VAS of 6.2 preoperatively
to 2.0 after one year. Unfortunately the evidence support-
ing the additional instrumentation after kyphoplasty is
very low. Therefore this procedure is promising, but it has
to be evaluated prospectively in the future.
Cement leakage
A feared complication of all vertebral augmentation tech-
niques is PMMA cement leakage. The systematic review of
the literature by Hulme et al [12] found rates of cement
leakage in vertebroplasty of 41% (n = 2,283 levels) and in
kyphoplasty of 9% (n = 1,486 levels) of treated vertebrae.
In the presented study we found radiographically con-
firmed cement leakage in 6.9% of all cases. These results
are lesser than average, but cement leakage was only iden-
tified on plain radiographs. CT-scans identify more leaks
than radiographs by a factor of 1.5 [36]. In kyphoplasty of
the 65 leakages reported in the literature most were par-
aspinal (48%), intradiscal (38%), epidural (11%), pul-
morary (1.5%) and foraminal (1.5%) [12]. Paraspinal
and intradiscal leakages generally are asymptomatic, even
This 68-year old man with corticoid-induced secondary oste- oporosis and multiple co-morbidity fell at home and pre- sented with osteoporotic fractures at T12 and L1 (a, b) Figure 4
This 68-year old man with corticoid-induced secondary oste-
oporosis and multiple co-morbidity fell at home and pre-
sented with osteoporotic fractures at T12 and L1 (a, b). The 
MRI confirmed fresh fractures and revealed a spinal stenosis 
at T12/L1 (c). Since non-surgical therapy was not successful, 
neurological deficits were not prevalent, kyphoplasty at T12 
and L1 was performed as a minimal intervention (d). Postop-
eratively the patient was mobilised and left the hospital 4 
days after kyphoplasty. Two weeks later the patient was 
admitted to our emergency care unit with incomplete para-
plegia sub T8. Laboratory diagostics revealed highly elevated 
leukocytes and C-reactive protein. Plain radiographs showed 
a thin radiolucency around the cement core on T12 (e). The 
MRI confirmed the suspected spondylitis and found addition-
ally an epidural abscess (f, g). Therefore posterior decom-
pression with instrumentation from T10 to L3 was 
performed and anterior corporectomy of T12 with complete 
cement removal and implantation of an expandable titanium-
cage and bone graft was performed (h). An incomplete para-
plegia sub L2 remained.P
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Table 1: Overview on comparative clinical trials (CT) of kyphoplasty
Author Year Design Level of 
evidence*
Control 
Group
Control 
n (levels)
Kyphoplasty 
n (levels)
Follow-up Outcome Cement leakage
Weisskopf et al. [56] 2003 Retrospective CT IIb non-surgical 20 (35) 22 (37) 10 days Improvement in VAS (p < 0.001)
Reduced days in hospital (p < 
0.01)
5 cement leakages in kyphoplasty
Fourney et al. [57] 2003 Retrrospective CT IIb vertebropla
sty
34 (65) 15 (32) 4,5 months No significant differences in VAS 
and ODI
Improvement of kyphosis with 
kyphoplasty (p < 0.01)
0 cement leakages in kyphoplasty
6 cement leakages in 
vertebroplasty
Komp et al. [58] 2004 Prospective CT IIa non-surgical 19(19) 21(21) 6 months Improvement of VAS and ODI (p 
< 0.01)
0 cement leakages in kyphoplasty
Kasperk et al [59] 2005 Prospective CT IIa non-surgical 20 (33) 40 (72) 12 months Improvement of VAS (p < 0.01)
Improve of kyphosis (p < 0.001).
7 cement leakages in kyphoplasty
Grohs et al. [60] 2005 Prospective CT IIa vertebropla
sty
23 (29) 28 (35) 24 months No significant difference in ODI
Improvement of VAS with 
kyphoplasty (p < 0.05)
No significant improve of kyphosis
8 cement leakages in kyphoplasty
8 cement leakages in 
vertebroplasty
Masala et al. [61] 2005 Retrospective CT IIb vertebropla
sty
26 (33) 7 (7) 6 months No significant difference in VAS. 0 cement leakage in kyphoplasty
11 cement leakages in 
vertebroplasty
Pflugmacher et al [62] 2005 Prospective CT IIa vertebropla
sty
20 (32) 22 (35) 12 months No significant difference in VAS 
and ODI
Improvement of kyphosis with 
kyphoplasty (p < 0.05)
5 cement leakages in kyphoplasty
6 cement leakages in 
vertebroplasty
De Negri et al. [63] 2007 Prospective CT IIa vertebropla
sty
10 (18) 11 (15) 6 months No significant difference in VAS 
and ODI
0 cement leakages in kyphoplasty
1 cement leakage in 
vertebroplasty
Frankel et al. [64] 2007 Retrospective CT IIb vertebropla
sty
19 (26) 17 (20) 6 months No significant difference in VAS
Higher rate of adjacent fractures 
with kyphoplasty (p < 0.05)
3 cement leakages in kyphoplasty
2 cement leakages in 
vertebroplasty
Müller et al [11] 2007 Randomized CT Ib non-surgical 149 151 3 months Improvement in SF-36 (p < 0.01) 
and VAS (p < 0.01) with 
kyphoplasty
Not reported
* Levels of evidence according to the recommendations of the US Agency for Health Care Policy and Research
VAS: Visual Analogous Scale, ODI: Oswestry Disability Index, SF-36: MOS-36 Item Short Form Health SurveryPatient Safety in Surgery 2008, 2:2 http://www.pssjournal.com/content/2/1/2
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though intradiscal leakage is blamed to promote adjacent
fractures [27]. Intradural cement leakage has only been
described for vertebroplasty so far [37], but epidural leak-
age had devastating neurological effects both in vertebro-
plasty [38] and in kyphoplasty [39]. These complications
can require immediate surgical intervention with decom-
pression and, if possible, removal of the cement causing
stenosis [40].
Pulmonary embolism of PMMA cement was found in
4.6% of the 65 patients treated with either vertebroplasty
(n = 88) or kyphoplasty (n = 25) by Choe et al [14]. No
correlation between the occurrence of pulmonary cement
embolism and the type of procedure was found. This is
remarkable since kyphoplasty has a much lesser rate of
cement leakage than vertebroplasty [12]. Pulmonary
cement embolism rarely requires intervention and mostly
remains asymptomatic. Often they are accidental findings
in chest radiographs, but there are several case reports
with clinically relevant cement embolisms. Jang et al [41]
presented three cases of cement embolisms after vertebro-
plasty, of which two had mild dyspnoea. No pulmonary
perfusion defects were seen and intervention was not nec-
essary. More severe is the case of François et al [42] with a
large PMMA cement embolus floating in the right pulmo-
nary artery menacing pulmonary function. Therefore the
embolus was removed by open heart surgery. In a case
report by Yoo et al [43] a 5 cm long PMMA cement embo-
lus in the right pulmonary artery after vertebroplasty lead
to acute respiratory distress syndrome, requiring intensive
care treatment and open embolectomy under cardiopul-
monary bypass. The patient did not recover and died ten
days after vertebroplasty. A further fatal pulmonary embo-
lism after vertebroplasty has been described by Monticelli
et al [44]. There is only one report on cement embolism
after kyphoplasty by Garfin et al. [45]. Reports on lethal
pulmonary cement embolism after kyphoplasty do not
exist.
With proper surgical techniques the risk of cement leakage
can be minimized. Correct placement of the balloon, high
viscosity of the PMMA cement, controlled application of
the cement in to the vertebra, and limitation of the
applied volume reduce the risk of leakage. A popular tech-
nique to reduce the risk of cement leakage in kyphoplasty
is the eggshell-technique, where after primary reduction
with the balloon a small amount of doughy cement is
applied into the cavity followed by re-inflation of the bal-
loon [46]. Using this technique a cement "eggshell" pre-
vents further leakage when the rest of the cement is
applied with radiographic control.
The severity of pulmonary PMMA cement embolism and
the urgent need of immediate decompression in relevant
spinal stenosis after cement leakage, questions the com-
mon practice of vertebroplasty and kyphoplasty in an out-
patient practice, without any spinal surgeon on call,
without any available operating theatres, and without an
intensive care unit. Even though fatal embolisms are few
kyphoplasty should not be regarded as minor interven-
tion which can be performed without the availability of
the above mentioned conditions and requirements.
Infections
Only two cases of infections after kyphoplasty have been
described so far in the available literature. Nussbaum et al
[47] found two cases of infection (discitis/osteomyelitis)
in the large "Food and Drug Administration" (FDA) data-
base for adverse events related to kyphoplasty devices. The
two presented cases with infection after kyphoplasty in
this study reflect the risk of infection being adherent to
every surgical intervention [48]. To our knowledge with
vertebroplasty only seven cases have been described with
postoperative infections. The vertebroplasty pioneers Der-
amond et al [7] presented one case of postoperative
spondylitis in an immunosuppressed patient, which
could be treated successfully by bedrest and antibiotics.
Kallmes et al [49] described a case of a postoperative infec-
tion in an immunocompromised patient. Another case
was presented by Yu et al [50] with severe pyogenic
spondylitis one month after vertebroplasty which was per-
formed while the patient had urinary tract infection. The
treatment was surgical with anterior corporectomy and
bisegmental fusion after multisegmental posterior instru-
mentation. A further case of spondylitis after vertebro-
plasty was presented by Schmid et al [51], which treated
the patient conservatively with a 3-month antibiotic regi-
men. Walker et al [52] and Mummameni et al [53] present
two additional cases of spondylitis after vertebroplasty
treated by anterior corporectomy and multisegemental
Table 2: Registered ongoing multicenter randomized controlled trials involving kyphoplasty []
Trial name Procedure Control group n Follow-up Primary outcome
FREE Kyphoplasty in VCF non-surgical 300 2 years Quality of life (SF-36)
CAFE Kyphoplasty in VCF in cancer patients non-surgical 200 1 year Pain (VAS), Disability (Roland-Morris)
CEEP Kyphoplasty in VCF vertebroplasty 112 2 years Pain (Roland-Scale)
KAVIAR Kyphoplasty in VCF vertebroplasty 1,234 2 years Subsequent fractures
VCF: Vertebral compression fracture, VAS: Visual Analogous Scale, SF-36: MOS-36 Item Short Form Health SurveyPatient Safety in Surgery 2008, 2:2 http://www.pssjournal.com/content/2/1/2
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fusion. Alfonso Olmos et al [54] report a case of spondyli-
tis after vertebroplasty requiring corporectomy and 360
degrees fusion. An unusual case report of spondylitis after
vertebroplasty with epidural abscesses containing myco-
bacterium tuberculosis was published by Bouvresse et al
[55]. This patient was under immunosuppression because
of a liver transplantation and an inactive tuberculous
lesion was obviously activated. Successful treatment
implied posterior decompression, abscess evacuation,
and long-term antituberculotic therapy.
Even though the risk of infection after kyphoplasty is
extremely low, infection does occur, as we have demon-
strated in this investigation. The available clinical experi-
ence from infection after vertebroplasty stresses the safety
limits of vertebral cement augmentation in immunocom-
promised patients. In these cases a standardized antibiotic
prophylaxis is recommended. Nevertheless the rate of
postoperative infections is lower both in kyphoplasty and
in vertebroplasty than in any other spinal surgical proce-
dure in general [48].
Conclusion
During the past five years kyphoplasty entered standard
VCF treatment protocols, replacing vertebroplasty in
many areas. Nevertheless conservative medical therapy
will not be easily replaced, since lack of reimbursement in
most countries causes an economic burden, many
patients are not willing to take. Furthermore it is still
unclear whether the benefits of kyphoplasty outweigh its
complications. The results of the case series presented here
demonstrate that kyphoplasty can be considered a safe
procedure, if performed in a hospital-based setting.
Although the overall complication rate is 15%, major
complications are rare. However, since severe acute com-
plications requiring emergency treatment may occur, we
believe that the procedure should be performed by a qual-
ified spine surgeon in a trauma center, exclusively.
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